Below the Belt Award

Our research group is aiming to create a new treatment for patients with bladder cancer. Durvalumab is a medicine that targets the body’s immune cells to help combat bladder cancer. When given intra-venously, durvalumab has proven effective at slowing advanced bladder cancer that has spread to other organs. We will recruit patients with bladder cancer who are recommended to have their bladder removed.